| Symbol | HCA |
|---|---|
| Name | HCA HEALTHCARE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Hospital/Nursing Management |
| Address | ONE PARK PLAZA, NASHVILLE, Tennessee, 37203, United States |
| Telephone | +1 615 344-9551 |
| Fax | — |
| — | |
| Website | https://www.hcahealthcare.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000860730 |
| Description | HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England. Additional info from NASDAQ: |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
Read moreHCA Healthcare - HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
Read moreHCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
Read moreHCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
Read more(30% Negative) HCA HEALTHCARE, INC. (HCA) Reports Q3 2026 Financial Results
Read moreHCA Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Saline | OTHER | Approved | Pain Management | COMPLETED | NCT00547664 |
| Hylenex recombinant , morphine, saline | DRUG | Approved | Pain Management | COMPLETED | NCT00547664 |